-
1.
公开(公告)号:US10774130B2
公开(公告)日:2020-09-15
申请号:US15866919
申请日:2018-01-10
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: Ray Camphausen , Eric Furfine , Irvith M. Carvajal , H. Nicholas Marsh , Marco Gottardis , Joan Carboni , Ricardo Attar
IPC: C07K14/05 , C07K14/78 , C07K16/46 , C07K16/28 , A61K38/16 , A61K38/17 , A61K38/18 , A61K38/39 , A61K47/60 , A61K39/395 , C07K14/71 , C07K14/715 , A61K39/00
Abstract: The present invention relates to multivalent polypeptides comprising at least two fibronectin scaffold domains connected via a polypeptide linker. The invention also relates to multivalent polypeptides for use in diagnostic, research and therapeutic applications. The invention further relates to cells comprising such proteins, polynucleotide encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the innovative proteins.
-
公开(公告)号:US10584160B2
公开(公告)日:2020-03-10
申请号:US15760449
申请日:2016-09-22
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: Dasa Lipovsek , Joseph Toth , Ginger C. Rakestraw , Irvith M. Carvajal , Stanley Richard Krystek, Jr. , Steven R. O'Neil , Guodong Chen , Richard Y. Huang , Bryan C. Barnhart , John Thomas Loffredo , Christina Terragni
Abstract: Provided herein are polypeptides which include tenth fibronectin type III domains (10Fn3) that bind to glypican-3. Also provided are fusion molecules comprising a 10Fn3 domain that bind to glypican-3 for use in diagnostic and therapeutic applications. Glypican-3 10Fn3 drug conjugates are also provided.
-
公开(公告)号:US11524992B2
公开(公告)日:2022-12-13
申请号:US16751788
申请日:2020-01-24
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: Dasa Lipovsek , Joseph Toth , Ginger C. Rakestraw , Irvith M. Carvajal , Stanley Richard Krystek, Jr. , Steven R. O'Neil , Guodong Chen , Richard Y. Huang , Bryan C. Barnhart , John Thomas Loffredo , Christina Terragni
Abstract: Provided herein are polypeptides which include tenth fibronectin type III domains (10Fn3) that bind to glypican-3. Also provided are fusion molecules comprising a 10Fn3 domain that bind to glypican-3 for use in diagnostic and therapeutic applications. Glypican-3 10Fn3 drug conjugates are also provided.
-
公开(公告)号:US09902762B2
公开(公告)日:2018-02-27
申请号:US14229415
申请日:2014-03-28
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: Ray Camphausen , Eric Furfine , Irvith M. Carvajal , H. Nicholas Marsh , Marco Gottardis , Joan Carboni , Ricardo Attar
IPC: C07K14/705 , C07K14/78 , C07K14/435 , C07K16/46 , C07K16/28 , A61K38/39 , A61K38/16 , A61K38/17 , A61K38/18 , A61K47/60 , A61K39/395 , C07K14/71 , C07K14/715 , A61K39/00
CPC classification number: C07K14/78 , A61K38/39 , A61K39/3955 , A61K47/60 , A61K2039/505 , C07K14/71 , C07K14/715 , C07K16/2863 , C07K2317/31 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2318/20 , C07K2319/00 , C07K2319/74
Abstract: The present invention relates to multivalent polypeptides comprising at least two fibronectin scaffold domains connected via a polypeptide linker. The invention also relates to multivalent polypeptides for use in diagnostic, research and therapeutic applications. The invention further relates to cells comprising such proteins, polynucleotide encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the innovative proteins.
-
-
-